Oxycodone Dosing for Moderate to Severe Pain Management

Initial Dosing and Titration

For moderate pain, low-dose oxycodone (starting at 5 mg) combined with acetaminophen can be effective, according to the European Society for Medical Oncology 1
The "breakthrough dose" for transient pain exacerbations should be approximately 10-15% of the total daily dose, as recommended by the European Society for Medical Oncology 1, 2
If more than four breakthrough doses per day are necessary, increase the baseline opioid regimen, as suggested by the European Society for Medical Oncology 2, 3

The relative potency ratio of oral oxycodone to oral morphine is approximately 1:1.5-2, meaning oxycodone is about 1.5-2 times more potent than morphine, according to the European Society for Medical Oncology 2
Controlled-release formulations are suitable for patients with stable opioid requirements and for maintenance therapy, as recommended by the European Society for Medical Oncology 2

Assess potential risks and benefits before initiating long-term opioid therapy, as recommended by the American Society of Clinical Oncology 4, 5
Use universal precautions to minimize abuse, addiction, and adverse consequences, as suggested by the American Society of Clinical Oncology 5

Laxatives should be routinely prescribed for both prophylaxis and management of opioid-induced constipation, as recommended by the European Society for Medical Oncology 6
Metoclopramide and antidopaminergic drugs are recommended for opioid-related nausea/vomiting, according to the European Society for Medical Oncology 6

For cancer pain management, oral morphine has traditionally been the first-line strong opioid, but oxycodone is an effective alternative with comparable efficacy, as suggested by the European Society for Medical Oncology and the American Society of Clinical Oncology 2, 5
For long-term use in cancer survivors, carefully weigh potential risks and benefits, as recommended by the American Society of Clinical Oncology 4, 5